Health

What will be the impact of PrEP in Ontario?

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Health, Research, Treatment, Revolving Door, Guest Authors, Media

The breadth of data being collected is intended to help answer the wide range of questions about what “real-world” PrEP use looks like in the province. Jack Mohr of the Ontario PrEP Cohort Study has this report.

What will be the impact of PrEP in Ontario?

After years spent waiting, more widespread access to Pre-Exposure Prophylaxis (PrEP) in Ontario finally seems to be taking shape. Health Canada approval for generic forms of tenofovir disoproxil fumarate/emtricitabine (the drug combination used for PrEP) has drastically decreased out of pocket costs for PrEP.  This development, along with concerted lobbying from HIV activists, also led to the addition of PrEP to the Ontario Drug Benefit formulary in September 2017. While these changes don’t

Study links gut-homing protein levels with HIV infection risk, disease progression

published: January, 30, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, Treatment Guidelines -including when to start, Women, Health, Research, International , Revolving Door, Treatment, Guest Authors, Media

From the National Institutes of Health: NIH clinical trial is testing antibody against the protein in people with HIV.

Study links gut-homing protein levels with HIV infection risk, disease progression

For the first time, scientists have shown a relationship between the proportion of key immune cells that display high levels of a gut-homing protein called alpha-4 beta-7 at the time of HIV infection and health outcomes. Previous research illustrated this relationship in monkeys infected with a simian form of HIV. The new study found that women who had more CD4+ T cells displaying high levels of alpha-4 beta-7 on their surface were more likely to become infected with HIV, and the virus damage

U=U laggards draw fire from the community

published: January, 29, 2018 Written by // Bob Leahy - Publisher Categories // African, Caribbean and Black, Activism, Social Media, Gay Men, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Women, Health, Treatment, Media, Opinion Pieces, Bob Leahy - Publisher

The Global U=U picture is good, but community activists are stepping up the heat on organizations which have been slow to embrace it. Today the spotlight is on Greater than AIDS, GNP+ and in Canada, the Ontario AIDS Network. Bob Leahy reports.

U=U laggards draw fire from the community

This article originallly appeared on January 16, 2018 If 2017 was a good year for many people living with HIV, it was for a simple, three character slogan that seemed to be everywhere. POZ.com, in awarding Undetectable equals Untransmittable, or U=U, the campaign of the year described it as “perhaps the most discussed and rapidly shared message to hit the HIV arena in years”. The Washington Post called it  “the campaign credited with beginning to change public perception of HIV trans

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

published: January, 29, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Health, International , Treatment, Revolving Door, Living with HIV, Guest Authors, Media

Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.From AIDSmap, Michael Carter reports.

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

The majority of HIV-positive women diagnosed with gynaecological cancer do not receive treatment recommended by cancer guidelines, according to research conducted in the United States and published in AIDS. Women whose care did not match guideline standards had poorer survival compared to women who received the recommended care. Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines. “To our knowledge, there is no case series de

French study confirms the safety and effectiveness of varenicline for HIV-positive smokers

published: January, 25, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Research, Health, International , CATIE - HIV and Hep C Info Resource, Smoking Cessation , Media

Varenicline (combined with counselling) can clearly help some HIV-positive people to quit smoking. From CATIE, Sean R. Hosein reports.

French study confirms the safety and effectiveness of varenicline for HIV-positive smokers

- People living with HIV are known to be at increased risk for smoking-related illnesses. - Researchers find varenicline safe and effective at helping people with HIV quit smoking. - Cessation counsellors who are infectious disease specialists have higher quit rates. The widespread use of potent HIV treatment (ART) has led to improved measures of health and near-normal life expectancy for many people with HIV in Canada and other high-income countries. However, studies have found that ART us

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

published: January, 24, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Treatment Guidelines -including when to start, Newly Diagnosed, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

“Our results show that any detectable viral load between 51 and 999 copies per ml leads to poorer treatment outcomes than successful virological suppression of less than 50 copies per ml,” write the investigators. From AIDSmap, Keith Alcorn reports.

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

Low-level HIV viral load, above the limit of detection, is an important warning signal for future treatment failure and World Health Organization guidelines on spotting treatment failure need to be revised to encourage greater vigilance and swifter action by healthcare providers in lower- and middle-income settings, investigators report in The Lancet Infectious Diseases. The study, carried out by Annemarie Wensing and colleagues at the University of Utrecht in the Netherlands and University

I’m a bad patient

published: January, 23, 2018 Written by // Bob Leahy - Publisher Categories // Aging, Social Media, Gay Men, General Health, Health, Living with HIV, Media, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy on those who stumble on the way to managing one’s health in the manner we are told to, and how he has got used to being a “bad” patient

I’m a bad patient

Colour me bad When I was diagnosed in 1993, I continued to work for six months, my life virtually unchanged except for a heavy heart and a secret few knew. I had time, though, to ponder the card that fate had dealt me. In 1994 I decided change was in order. So I left work for good, disclosed to everybody in sight and plunged into volunteerism. My first volunteer job involved manning the reception desk at ACT, then called the AIDS Committee of Toronto.  I thrived. During quiet times at the r

PrEP’s social impact on the lives of some gay men in Toronto

published: January, 23, 2018 Written by // Guest Authors - Revolving Door Categories // Dating, African, Caribbean and Black, As Prevention , Gay Men, Youth, Treatment Guidelines -including when to start, Research, Health, Sexual Health, CATIE - HIV and Hep C Info Resource, Lifestyle, Treatment, Living with HIV

Researchers in Toronto conducted a PrEP demonstration project to assess its acceptability, use and effectiveness. From CATIE, Sean R. Hosein reports.

PrEP’s social impact on the lives of some gay men in Toronto

- Researchers interviewed early adopters of PrEP in Toronto about their experience. - Participants reported that their use of PrEP left them feeling “proud” and “liberated.” - Stigma and judgment related to PrEP also led some participants to conceal their use of it. PrEP (pre-exposure prophylaxis) involves taking two anti-HIV medicines in one pill, usually daily, to reduce the chance of getting HIV. PrEP is meant to be used in combination with other HIV prevention approaches, such a

The Diva Flu

published: January, 22, 2018 Written by // Patrick Italo Ettenes Categories // African, Caribbean and Black, Aging, Gay Men, General Health, Health, International , Living with HIV, Patrick Italo Ettenes

Patrick Ettenes: "Let’s be frank, none of us are wonderful when sick."

The Diva Flu

Happy 2018 everyone! I trust that everyone had a great New Year celebration without any drama?  I laugh, as of course I didn’t and pushing forward, I will discuss that drama one day in the future, after I’m done pulling the pins out of the voodoo doll that represents the individual (smiling ever so cheeky). So let’s push forward. After my New Year’s I became Ill. The trauma I went through and the partying had a toll on me and of course my body was run down and I became sick. Laying o

The power of "no"

published: January, 22, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Health, Legal, Lifestyle, Revolving Door, Media, Guest Authors, Opinion Pieces, Sex and Sexuality

From FS Magazine, Hadley Stewart: "Despite having consented to sex, we don’t necessarily make it clear what we’re consenting to. How able do you feel to negotiate in the bedroom?"

The power of

If, like me, you’ve never sat down and thought about the term ‘consent’, you’d be forgiven for thinking that it doesn’t really apply to you. Often we associate the term with the law, meaning that it’s easy to think it’s something that doesn’t form part of our lives unless we’ve been the victim of a crime. A sexual assault, for instance, is often paired up with the notion of consent. So does that mean we’ve never consented to anything or used our power of consent? Probably

So you tested positive for HIV

published: January, 19, 2018 Written by // Kimutai Kemboi, Categories // African, Caribbean and Black, Social Media, Activism, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Newly Diagnosed, General Health, Mental Health, Health, International , Sexual Health, Treatment, Living with HIV, Opinion Pieces

Kimutai Kemboi of Kenya offers his best advice for those newly diagnosed with HIV.

So you tested positive for HIV

So you tested for HIV a few hours, days, weeks, months or years ago and you found out that you are HIV-positive. I know that was the last thing you expected, yet you must have been worried since that day you messed up somewhere or unwillingly/unknowingly got involved in a mess. Don't even burden yourself with thinking of that; it is absolutely not important. What is important is what you do after getting the facts. Immediately you saw two lines appearing in that testing kit, your mind went i

Long-acting injectable ARVs are convenient and private, study participants report

published: January, 18, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Health, Research, International , Treatment, Revolving Door, Living with HIV, Guest Authors, Media

From NAM aidsmap, Roger Pebody reports on two studies, one using long-acting injectables as TasP and one using them as PrEP.

Long-acting injectable ARVs are convenient and private, study participants report

HIV-positive people who took injectable cabotegravir + rilpivirine every four or eight weeks as antiretroviral therapy found it more convenient and discreet than daily pills, also feeling that it eliminated a “daily reminder of living with HIV”, Deanna Kerrigan and colleagues report in PLOS One. Similarly, HIV-negative men who took injectable cabotegravir every 12 weeks as pre-exposure prophylaxis (PrEP) felt that it was probably more convenient and easier to adhere to than dai

Happy new year. Being marked by Big City Living

published: January, 17, 2018 Written by // Dennis Battler Categories // Social Media, Aging, Gay Men, Health, Pets, Spirituality, Lifestyle, Living with HIV, Opinion Pieces, Dennis Battler

Toronto poz guy Dennis Battler: 'Hi Robert To bring you up to date I've attached a "summary" of sorts ... Possibly this review sent to a friend could be manipulated into an article. Today's word is "painting." Happy new year.

Happy new year. Being marked by Big City Living

Hello Sheila, To respond to your email thoroughly (I believe you appreciate detail as much as I) I’m sending along a reply I wrote to Eric whom I worked with at Of Things Past. Eric also had a Whippet, Hudson, whom Shanti visited with. One day a week for a year when I set up the Rosedale store, Hudson and Shanti were canine staples there with many fans. Eric kindly sent this email: “Greetings Dennis. I wanted to reach out and send along well wishes for the holidays.  I know how challen

Common birth control shot linked to risk of HIV infection

published: January, 17, 2018 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

Research indicates alternative contraception methods may help protect women.

Common birth control shot linked to risk of HIV infection

Washington, DC - Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Society’s journal Endocrine Reviews. The predominant contraceptive in Sub-Saharan Africa is depot-medroxyprogesterone acetate (DMPA)—a birth control shot administered every three months. Human studies suggest DMPA use may raise the risk of H

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

published: January, 16, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, General Health, Mental Health, Research, Health, Sexual Health, Revolving Door, Lifestyle, Treatment, Guest Authors, Media

From NAM AIDSmap, Roger Pebody reports on two Toronto studies that shed light on how PrEP stigma is affecting PrEP uptake.

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men acknowledged that they did not always use condoms but did not see themselves as the kind of ‘barebacker’ for whom they thought PrEP was intended. “PrEP embodies the notion of bareback sex, which traditionally has been associated with negative elements, and it is quite clear that the young gay men in this re

<<  1 [23 4 5 6  >>